に関する追加情報 Minocycline EP Impurity G
親薬物
MinocyclineIUPAC名
(4S, 4aS, 5aR, 12aS)-4, 7, 9-Tris(dimethylamino)-3, 10, 12, 12a-tetrahydroxy-1, 11-dioxo-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydrotetracene-2-carboxamide hydrochloride薬局方同義語
N/AOther Synonyms
9-Dimethylamino Minocycline Hydrochloride/ Minocycline 4,7,9-Tris-Dimethylamino Impurity HydrochlorideSMILES
O=C(C1=C(O)[C@@H](N(C)C)[C@@](C[C@@]2([H])C(C(C3=C(O)C(N(C)C)=CC(N(C)C)=C3C2)=O)=C4O)([H])[C@@]4(O)C1=O)N.[H]ClInchl
InChI=1S/C25H32N4O7.ClH/c1-27(2)13-9-14(28(3)4)19(30)16-11(13)7-10-8-12-18(29(5)6)21(32)17(24(26)35)23(34)25(12,36)22(33)15(10)20(16)31;/h9-10,12,18,30,32-33,36H,7-8H2,1-6H3,(H2,26,35);1H/t10-,12-,18-,25-;/m0./s1説明
The compound Minocycline EP Impurity G is a highly characterized reference material that meets stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Minocycline production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally, the product comes with a detailed Structure Elucidation Report (SER), ensuring its precision and reliability for comprehensive analytical use.
見積もり依頼
「*」は必須フィールドを示します









